MGMT and glioblastoma: One study showed that glioblastoma patients with the dual inactivation of MGMT, by loss of the long arm of chromosome 10 and the hypermethylation of the MGMT promoter, have longer progression-free survival and overall survival, and respond well to temozolomide therapy [32,79].